STEMCELL Technologies

About STEMCELL Technologies

STEMCELL Technologies Inc. operates as a key supplier to the global life sciences research market, providing the essential tools and reagents for scientific advancement. The company was established in 1993 by Dr. Allen Eaves, a distinguished hematologist and cancer researcher. Its creation stemmed from a direct need within Dr. Eaves' own research at the Terry Fox Laboratory in Vancouver, where his team began producing their own standardized cell culture media for hematopoietic stem cells due to dissatisfaction with commercially available options. To fund his cancer research, Dr. Eaves began selling this proprietary medium, named MethoCult™, to other researchers, eventually purchasing the business from the laboratory to launch STEMCELL Technologies.

The company's business model revolves around the development, manufacturing, and sale of a comprehensive portfolio of over 2,500 products. Its revenue is generated through direct sales to research laboratories, academic institutions, and biotechnology companies in more than 70 countries, with 97% of sales occurring outside of Canada. The financial strategy involves reinvesting all profits back into research and development, which has sustained an average annual growth rate of 20% since its inception. This private ownership structure allows for a long-term focus on product development and quality control.

The product catalog is extensive, serving scientists in fields such as stem cell research, immunology, cancer, regenerative medicine, and cellular therapy. Core offerings include specialty cell culture media, cell separation and isolation technologies like immunomagnetic reagents, antibodies, cytokines, and various accessory products. Furthermore, the company manufactures instruments for robotic cell separation and analysis. Beyond products, STEMCELL provides a range of services, including contract research, custom reagent solutions, and scientific training programs, embodying its mission as "Scientists Helping Scientists".